Daniel Caserza, interim chief financial officer of Ciphergen Biosystems, is expected to resign this week, according to documents filed with the Securities and Exchange Commission. He became the interim CFO in March after Matthew Hogan abruptly resigned.
Gail Page, the company's president and chief executive officer, will act as interim chief financial officer until the company finds a permanent replacement.
Ciphergen has hired the Financial Leadership Group to help it prepare financial statements until a replacement is appointed.
Stephen Scherer has joined CombiMatrix Molecular Diagnostics' science advisory board.
Scherer is a senior scientist in genetics and genomic biology at The Hospital for Sick Children in Canada and associate professor of medicine at the University of Toronto. He is also director of the Centre for Applied Genomics and associate chief of research at the hospital.
CombiMatrix Molecular Diagnostics is wholly owned by CombiMatrix.